[EN] INHIBITORS OF HCV NS5A<br/>[FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C DE TYPE NS5A
申请人:PRESIDIO PHARMACEUTICALS INC
公开号:WO2010065681A1
公开(公告)日:2010-06-10
The invention relates to non-macrocyclic, non-peptidic, substituted heterocyclic compounds useful for inhibiting hepatitis C virus ("HCV") replication, particularly functions of the non-structural 5A ("NS5A") protein of HCV
Selective C−H Halogenation with a Highly Fluorinated Manganese Porphyrin
作者:Gang Li、Andrew K. Dilger、Peter T. Cheng、William R. Ewing、John T. Groves
DOI:10.1002/anie.201710676
日期:2018.1.26
functionalization of aliphatic molecules remains a challenge in organic synthesis. While radical chain halogenation reactions provide efficient access to many halogenated molecules, the use of typical protocols for the selective halogenation of electron‐deficient and strained aliphatic molecules is rare. Herein, we report selective C−H chlorination and fluorination reactions promoted by an electron‐deficient